Stock & Company Details
Adma Biologics Inc $ADMA
Price:
N/A
N/A
224M
$2.3B
52 Week High:
N/A
10 Day Average Volume:
N/A
14.69
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ADMA technical indicators
Latest Adma Biologics Inc (ADMA) indicator readings as of 2026-10-09.
ADMA's 14-day RSI is 62.9, in neutral territory. At $10.36 it is trading 10.1% below its 200-day moving average of $11.53, and above its 50-day average of $9.57. Price sits near the upper Bollinger Band ($8.67 to $10.68). ADX reads 19.1, indicating a range-bound market rather than a trend.
Overview
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services.
Finance Bot
Ask your questions
Start by typing a question below.
